Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance

Go back to Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance
NEOGENOMICS (NASDAQ: NEO) Delayed: 16.63 +0.06 (0.36%)
Previous Close $16.57    52 Week High $9.54 
Open $16.53    52 Week Low $5.49 
Day High $16.92    P/E 415.75 
Day Low $16.33    EPS $0.04 
Volume 1,945,747